{"id":482975,"date":"2024-01-10T22:10:40","date_gmt":"2024-01-11T06:10:40","guid":{"rendered":"https:\/\/nai500.com\/blog\/2024\/01\/%e5%87%8f%e8%82%a5%e8%8d%af%e6%a6%82%e5%bf%b5%e8%82%a1-2024%e5%b9%b4-%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e7%83%ad%e7%82%b9\/"},"modified":"2024-01-10T22:10:58","modified_gmt":"2024-01-11T06:10:58","slug":"%e6%b8%9b%e8%82%a5%e8%97%a5%e6%a6%82%e5%bf%b5%e8%82%a1-2024%e5%b9%b4-%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e7%86%b1%e9%bb%9e","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2024\/01\/%e6%b8%9b%e8%82%a5%e8%97%a5%e6%a6%82%e5%bf%b5%e8%82%a1-2024%e5%b9%b4-%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e7%86%b1%e9%bb%9e\/","title":{"rendered":"\u6e1b\u80a5\u85e5\u6982\u5ff5\u80a1\uff0c2024\u5e74\u4e0d\u80fd\u4e0d\u8ffd\u7684\u751f\u7269\u79d1\u6280\u71b1\u9ede"},"content":{"rendered":"<p>\u751f\u7269\u79d1\u6280\u80a1\u7968\u4f9d\u7136\u662f\u7f8e\u80a1\u5e02\u5834\u4e0a\u7684\u71b1\u9ede\u4e4b\u4e00\uff0c\u53ea\u8981\u9078\u5c0d\u80a1\u7968\uff0c\u5de8\u984d\u6536\u76ca\u4e0d\u662f\u5922\u3002\u770b\u770b\u6e1b\u80a5\u85e5\u80a1\u7968\u79ae\u4f86Eli Lilly and Co\uff08NYSE:LLY\uff09\uff0c\u9019\u5bb6\u9ad8\u5e02\u503c\u88fd\u85e5\u5de8\u982d\u7684\u80a1\u50f9\u5728\u6e1b\u80a5\u85e5\u9019\u500b\u71b1\u9ede\u7684\u63a8\u52d5\u4e4b\u4e0b\u5f9e460\u7f8e\u5143\u4e00\u8def\u6f32\u5230626\u7f8e\u5143\u3002\u518d\u770b\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968CRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09\uff0c\u7f8e\u570bFDA\u6279\u51c6\u4e86\u5b83\u7684\u9996\u6b3e\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u4e4b\u524d\uff0c\u8a72\u80a1\u80a1\u50f9\u5f9e37.50\u7f8e\u5143\u66b4\u6f32\u523075\u7f8e\u5143\u3002<\/p>\n<p>\u6211\u60f3\u8981\u8aaa\u7684\u662f\uff0c\u751f\u7269\u79d1\u6280\u884c\u696d\u6a5f\u6703\u773e\u591a\uff0c\u5f9e\u4e0d\u7f3a\u5c11\u5275\u5bcc\u6a5f\u6703\uff0c\u6bd4\u5982\u8aaa\u7576\u4e0b\u706b\u71b1\u7684\u6e1b\u80a5\u85e5\u6982\u5ff5\u4ee5\u53ca\u90193\u53ea\u751f\u7269\u79d1\u6280\u80a1\u7968\u3002<\/p>\n<h2>\u6e1b\u80a5\u85e5\u6982\u5ff5\u80a11\uff1aViking Therapeutics<\/h2>\n<p>\u9664\u4e86\u79ae\u4f86\uff0c\u6e1b\u80a5\u85e5\u6982\u5ff5\u80a1\u9084\u6709<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=VKTX\">Viking Therapeutics Inc\uff08NASDAQ:VKTX\uff09<\/a>\uff0c\u6700\u8fd1\u8a72\u80a1\u80a1\u50f9\u4e5f\u5f9e\u5927\u7d049\u7f8e\u5143\u6f32\u5230\u4e8619.50\u7f8e\u5143\uff0c\u800c\u4e14\u63a5\u4e0b\u4f86\u9084\u6709\u7e7c\u7e8c\u4e0a\u6f32\u7684\u6f5b\u529b\u3002\u8a72\u516c\u53f8\u6e1b\u80a5\u5019\u9078\u85e5\u7269VK2735\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\u525b\u525b\u5b8c\u6210\u60a3\u8005\u62db\u52df\uff0c\u7814\u7a76\u7d50\u679c\u9810\u8a08\u5c07\u5728\u4eca\u5e74\u4e0a\u534a\u5e74\u767c\u4f48\u3002\u4e00\u671f\u7d50\u679c\u986f\u793a\uff0c\u60a3\u8005\u6e1b\u91cd\u6700\u9ad8\u90548%\uff0c\u4e8c\u671f\u7684\u6578\u64da\u61c9\u8a72\u4e5f\u4e0d\u932f\u3002<\/p>\n<p>\u9664\u4e86\u7814\u767c\u7ba1\u7dda\uff0cVKTX\u9084\u6709\u53ef\u80fd\u6210\u70ba\u6536\u8cfc\u76ee\u6a19\uff0c\u6bd4\u5982\u8aaa\u7f85\u6c0f\u63a7\u80a1Roche Holding\uff08PINX:RHHBY\uff09\u525b\u525b\u4ee531\u5104\u7f8e\u5143\u7684\u50f9\u683c\u6536\u8cfc\u4e86\u6e1b\u80a5\u85e5\u88fd\u9020\u5546Carmot Therapeutics\u3002<\/p>\n<h2>\u6e1b\u80a5\u85e5\u6982\u5ff5\u80a12\uff1aAltimmune<\/h2>\n<p>\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u88fd\u85e5\u516c\u53f8Altimmune Inc.\uff08NASDAQ:ALT\uff09\u4e5f\u662f\u4e00\u96bb\u6e1b\u80a5\u85e5\u6982\u5ff5\u80a1\uff0c\u8a72\u516c\u53f8\u4e3b\u8981\u7684\u5019\u9078\u7522\u54c1\uff0cGLP-1\/\u80f0\u9ad8\u8840\u7cd6\u7d20\u96d9\u53d7\u9ad4\u6fc0\u52d5\u5291pemvidutide\u525b\u525b\u516c\u4f48\u4e86\u4e8c\u671f\u80a5\u80d6\u75c7\u8a66\u9a57\u7a4d\u6975\u7684\u9802\u7dda\u7d50\u679c\u3002\u6309\u7167JMP Securities\u7684\u8aaa\u6cd5\uff0c\u5b83\u7684\u6e1b\u91cd\u6548\u679c\u751a\u81f3\u512a\u65bc\u8afe\u548c\u8afe\u5fb7Novo Nordisk\uff08NYSE:NVO\uff09\u7684Wegovy\u3002JMP\u8868\u793a\uff0cPemvidutide\u7684\u6e1b\u91cd\u6548\u679c\u512a\u65bc\u53f8\u7f8e\u683c\u9b6f\u80bd\uff0c\u8102\u8cea\u8b8a\u5316\u548c\u8010\u53d7\u6027\u512a\u65bc\u66ff\u897f\u5e15\u80bd\uff0c\u5fc3\u81df\u5b89\u5168\u6027\u512a\u65bc\u745e\u4ed6\u9b6f\u80bd\u3002<\/p>\n<p>\u5f97\u76ca\u65bc\u6b64\uff0cALT\u80a1\u50f9\u5df2\u7d93\u5f9e\u5927\u7d043\u7f8e\u5143\u6f32\u5230\u4e8611.40\u7f8e\u5143\uff0c\u672a\u4f86\u6709\u671b\u7ffb\u500d\u3002<\/p>\n<h2>\u6e1b\u80a5\u85e5\u6982\u5ff5\u80a13\uff1aOmega Therapeutics<\/h2>\n<p>Omega Therapeutics, Inc.\uff08NASDAQ:OMGA\uff09\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\uff0c\u805a\u7126\u65bc\u7814\u767c\u53ef\u7de8\u7a0b\u8868\u89c0\u57fa\u56e0\u7d44mRNA\u85e5\u7269\u7684\u751f\u7269\u88fd\u85e5\u516c\u53f8\u300211\u6708\u4ee5\u4f86\uff0c\u8a72\u80a1\u80a1\u50f9\u5f9e1.30\u7f8e\u5143\u7684\u4f4e\u9ede\u6f32\u5230\u8fd1\u671f\u9ad8\u9ede\u76846.30\u7f8e\u5143\uff0c\u6700\u8fd1\u56de\u843d\u81f34.35\u7f8e\u5143\u3002Omega\u7684\u6e1b\u80a5\u85e5\u6982\u5ff5\u4f86\u81ea\u65bc\u8a72\u516c\u53f8\u8207\u8afe\u548c\u8afe\u5fb7\u7c3d\u7f72\u4e86\u4e00\u9805\u7814\u7a76\u5354\u8b70\uff0c\u96d9\u65b9\u5c07\u501f\u52a9Omega\u7684\u5c08\u6709\u5e73\u81fa\u6280\u8853\u4ee5\u53ca\u8afe\u548c\u8afe\u5fb7\u7684\u5fc3\u8840\u7ba1\u4ee3\u8b1d\u7814\u7a76\u5be6\u529b\u958b\u767c\u4e00\u500b\u65b0\u578b\u7684\u6cbb\u7642\u80a5\u80d6\u75c7\u7684\u8868\u89c0\u57fa\u56e0\u7d44\u63a7\u5236\u5668\u3002\u8a72\u63a7\u5236\u5668\u6709\u671b\u901a\u904e\u5f37\u5316\u751f\u71b1\u4f5c\u7528\u4f86\u5f37\u5316\u65b0\u9673\u4ee3\u8b1d\u3002<\/p>\n<p>H.C. Wainwright\u7684\u5206\u6790\u5e2b\u5c07Omega Therapeutics\u7684\u76ee\u6a19\u80a1\u50f9\u5f9e11\u7f8e\u5143\u4e0a\u8abf\u81f312\u7f8e\u5143\uff0c\u80a1\u7968\u8a55\u7d1a\u201c\u8cb7\u5165\u201d\u3002\u540c\u6642\uff0cWedbush\u5206\u6790\u5e2b\u7684\u76ee\u6a19\u50f9\u70ba12\u7f8e\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u7269\u79d1\u6280\u80a1\u7968\u4f9d\u7136\u662f\u7f8e\u80a1\u5e02\u5834\u4e0a\u7684\u71b1\u9ede\u4e4b\u4e00\uff0c\u53ea\u8981\u9078\u5c0d\u80a1\u7968\uff0c\u5de8\u984d\u6536\u76ca\u4e0d\u662f\u5922\u3002\u770b\u770b\u6e1b\u80a5\u85e5\u80a1\u7968\u79ae\u4f86Eli Lilly a [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":482973,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,2156,927,564],"class_list":["post-482975","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-2156","tag-927","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/482975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=482975"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/482975\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/482973"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=482975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=482975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=482975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}